Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 of Wall Street’s Favorite Stock Worth Investigating and 2 Facing Headwinds

1 of Wall Street’s Favorite Stock Worth Investigating and 2 Facing Headwinds

NATR : 27.34 (+4.03%)
RMD : 228.12 (+1.51%)
FA : 12.39 (-0.96%)
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday,...

RMD.AX : 31.780 (+0.82%)
RMD : 228.12 (+1.51%)
ResMed Earnings Preview: What to Expect

ResMed is set to announce its third-quarter earnings soon, and Wall Street expects the company’s EPS to increase by double digits.

XLV : 148.26 (-0.36%)
$SPX : 7,126.06 (+1.20%)
RMD : 228.12 (+1.51%)
Unpacking Q4 Earnings: ResMed (NYSE:RMD) In The Context Of Other Patient Monitoring Stocks

Unpacking Q4 Earnings: ResMed (NYSE:RMD) In The Context Of Other Patient Monitoring Stocks

RMD : 228.12 (+1.51%)
Is ResMed Stock Underperforming the Nasdaq?

ResMed has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

$NASX : 24,468.48 (+1.52%)
RMD : 228.12 (+1.51%)
BAX : 18.35 (-1.92%)
ResMed (RMD) Stock Trades Down, Here Is Why

ResMed (RMD) Stock Trades Down, Here Is Why

RMD : 228.12 (+1.51%)
3 Healthcare Stocks to Target This Week

3 Healthcare Stocks to Target This Week

NTRA : 208.00 (-0.19%)
GMED : 95.25 (+2.68%)
RMD : 228.12 (+1.51%)
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains  53% of people surveyed rank sleep as the most important behavior for a long,...

RMD.AX : 31.780 (+0.82%)
RMD : 228.12 (+1.51%)
Richmond Commences Drilling Program at Aguara East

TORONTO, ON / ACCESS Newswire / February 26, 2026 / Richmond Minerals Inc. (TSX-V:RMD) ("Richmond" or the "Company") is pleased to provide an update for exploration work at the Company's Ridley Lake Gold...

RMD.VN : 0.145 (unch)
RMD : 228.12 (+1.51%)
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution...

RMD.AX : 31.780 (+0.82%)
RMD : 228.12 (+1.51%)

Barchart Exclusives

Is Irrational Market Behavior Predictable?
The past decade has taught has to predict what will be said, and why, leading to the rise of predictive market websites as "trading" platforms, among other things. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.